News
Venture Challenge alumnus Nutrileads wins FI Europe Innovation Award
BeniCaros™ the proprietary immune health ingredient has won the FI Europe Innovation Award in the Health Innovation Category
Eureka Eurostars awarded to Venture Challenge Winner BIMINI Biotech
BIMINI Biotech was recently awarded a Eureka Eurostars project with the aim of targeting the growth hormone receptor for novel and personalized cancer therapeutics.
Venture Challenge alumnus CC Diagnostics appoints new CEO
CC Diagnostics is proud to announce the appointment of Ronald Vos as the companies Chief Executive Officer. Ronald brings over 30 years of busi
Venture Challenge alumnus ATRO Medical initiates clinical trial
ATRO Medical has reached an important stage in tackling post-meniscectomy knee pain with the initiation of their clinical trial "AIR2"
Venture Challenge Winner Ncardia Secures $60+ Million to Enhance and Expand Leading iPSC Offerings
Gosselies, Belgium and New York, N.Y. - Ncardia forms strategic partnership with Kiniciti to build GMP capabilities to support iPSC cell therapy platforms and human cell-based in vitro discovery services
Venture Challenge alumnus Protinhi Therapeutics selected as part of BLUE KNIGHT™ collaboration for pandemic preparedness
Nijmegen -- Protinhi Therapeutics, a Netherlands-based biotechnology company specializing in protease inhibition with the aim to combat viral infectious diseases, today announced it has been se
Venture Challenge alumnus MyLife Technologies raises €3.5 million to develop its vaccine delivery technology via ceramic vaccine patches for 'Pandemic Preparedness'
Leiden, – MyLife Technologies, which focuses on the development of ceramic vaccine patches for the simple, efficient and painless administration of vaccines through the skin, has raised €3.5 million from Fare Capital BV, SAL Beheer BV, informal inve
Venture Challenge Winner SeraNovo Enters into License Agreement with Équilibre BioPharmaceuticals.
SeraNovo BV (Leiden, The Netherlands) is pleased to announce the closing of a License Agreement with Équilibre BioPharmaceuticals Corporation (New York, USA), a biopharmaceutical company engaged in the research and development of small molecules in
Venture Challenge alumnus Scope Biosciences raises €1 Million funding from GenDx
WAGENINGEN - Diagnostic startup company Scope Biosciences B.V. has raised €1 Million funding from Utrecht based GenDx, specialized in Next Generation Sequencing (NGS) products for transplant diagnostics.
Venture Challenge alumnus Praxa Sense initiates first clinical trial
Last month, Praxa Sense has started the first clinical trial with their Afi product at Reinier de Graaf ziekenhuis.